These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 20713568)
1. Almotriptan efficacy in migraine with allodynia: a rebuttal to Burstein and Jakubowski's critique of Schoenen et al. Schoenen J; Vandenheede M Cephalalgia; 2010 Sep; 30(9):1147-8. PubMed ID: 20713568 [No Abstract] [Full Text] [Related]
2. Almotriptan efficacy in migraine with allodynia: a critique of Schoenen et al. Burstein R; Jakubowski M Cephalalgia; 2009 Oct; 29(10):1019-20. PubMed ID: 19366354 [No Abstract] [Full Text] [Related]
3. Almotriptan for the acute treatment of adolescent migraine. Lewis DW Expert Opin Pharmacother; 2010 Oct; 11(14):2431-6. PubMed ID: 20828268 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the START study. Lanteri-Minet M; Díaz-Insa S; Leone M; Vila C; Clissold SP; Int J Clin Pract; 2010 Jun; 64(7):936-43. PubMed ID: 20584227 [TBL] [Abstract][Full Text] [Related]
5. Almotriptan efficacy in migraine with developing allodynia is as high as the efficacy in migraine without allodynia--but is it the same in migraine with established allodynia? Burstein R Headache; 2009 Mar; 49(3):364-5. PubMed ID: 19267784 [No Abstract] [Full Text] [Related]
6. Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents. Berenson F; Vasconcellos E; Pakalnis A; Mao L; Biondi DM; Armstrong RB Headache; 2010 May; 50(5):795-807. PubMed ID: 20546320 [TBL] [Abstract][Full Text] [Related]
7. Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study. Leone M; Vila C; McGown C Expert Rev Neurother; 2010 Sep; 10(9):1399-408. PubMed ID: 20819011 [TBL] [Abstract][Full Text] [Related]
8. Almotriptan and its combination with aceclofenac for migraine attacks: a study of efficacy and the influence of auto-evaluated brush allodynia. Schoenen J; De Klippel N; Giurgea S; Herroelen L; Jacquy J; Louis P; Monseu G; Vandenheede M; Cephalalgia; 2008 Oct; 28(10):1095-105. PubMed ID: 18644036 [TBL] [Abstract][Full Text] [Related]
9. Almotriptan for the treatment of acute migraine: a review of early intervention trials. Antonaci F; De Cillis I; Cuzzoni MG; Allena M Expert Rev Neurother; 2010 Mar; 10(3):351-64. PubMed ID: 20187858 [TBL] [Abstract][Full Text] [Related]
10. Almotriptan in the acute treatment of migraine in patients 11-17 years old: an open-label pilot study of efficacy and safety. Charles JA J Headache Pain; 2006 Apr; 7(2):95-7. PubMed ID: 16688412 [TBL] [Abstract][Full Text] [Related]
11. Increasing the effect of triptans in migraine. Tfelt-Hansen P; Olesen J Lancet; 2006 Oct; 368(9544):1313-4. PubMed ID: 17046449 [No Abstract] [Full Text] [Related]
12. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046 [TBL] [Abstract][Full Text] [Related]
13. Use of almotriptan in triptan-experienced and triptan-naïve patients. Pascual J; Diener HC Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629 [TBL] [Abstract][Full Text] [Related]
15. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials. Dahlöf CG; Pascual J; Dodick DW; Dowson AJ Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240 [TBL] [Abstract][Full Text] [Related]
16. Comparison chart of triptans. Med Lett Drugs Ther; 2017 Feb; 59(1514):e27-e29. PubMed ID: 28170367 [No Abstract] [Full Text] [Related]
19. Migraine in the triptan era: progresses achieved, lessons learned and future developments. Bigal ME; Krymchantowski AV; Ho T Arq Neuropsiquiatr; 2009 Jun; 67(2B):559-69. PubMed ID: 19623468 [TBL] [Abstract][Full Text] [Related]
20. [Naratriptan. A new medical option for the pharmacist]. Kunkel M Med Monatsschr Pharm; 2007 May; 30(5):184-6. PubMed ID: 17526395 [No Abstract] [Full Text] [Related] [Next] [New Search]